• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells.细胞表面相关NS1的抗体识别触发Fc-γ受体介导的吞噬作用并清除西尼罗河病毒感染的细胞。
J Virol. 2007 Sep;81(17):9551-5. doi: 10.1128/JVI.00879-07. Epub 2007 Jun 20.
2
Human Monoclonal Antibodies against NS1 Protein Protect against Lethal West Nile Virus Infection.人源抗 NS1 蛋白单克隆抗体可预防致死性西尼罗河病毒感染。
mBio. 2021 Oct 26;12(5):e0244021. doi: 10.1128/mBio.02440-21. Epub 2021 Oct 12.
3
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.针对西尼罗河病毒非结构蛋白NS1的抗体通过Fcγ受体依赖性和非依赖性机制预防致死性感染。
J Virol. 2006 Feb;80(3):1340-51. doi: 10.1128/JVI.80.3.1340-1351.2006.
4
Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc Receptor-Dependent and -Independent Pathways.抗寨卡病毒 NS1 蛋白的单克隆抗体通过 Fc 受体依赖性和非依赖性途径发挥保护作用。
mBio. 2021 Feb 9;12(1):e03179-20. doi: 10.1128/mBio.03179-20.
5
Role of NS1 and TLR3 in Pathogenesis and Immunity of WNV.NS1 和 TLR3 在西尼罗河病毒发病机制和免疫中的作用。
Viruses. 2019 Jul 3;11(7):603. doi: 10.3390/v11070603.
6
Replication-Defective West Nile Virus with NS1 Deletion as a New Vaccine Platform for Flavivirus.复制缺陷型西尼罗河病毒 NS1 缺失突变体作为黄病毒新型疫苗平台。
J Virol. 2019 Aug 13;93(17). doi: 10.1128/JVI.00720-19. Print 2019 Sep 1.
7
A cross-protective mAb recognizes a novel epitope within the flavivirus NS1 protein.一种具有交叉保护作用的单抗识别黄病毒 NS1 蛋白内的一个新表位。
J Gen Virol. 2012 Jan;93(Pt 1):20-26. doi: 10.1099/vir.0.036640-0. Epub 2011 Sep 14.
8
Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1.西尼罗河病毒(WNV)和日本脑炎病毒血清型特异性线性 B 细胞表位的综合图谱来自 WNV 非结构蛋白 1。
J Gen Virol. 2012 Jan;93(Pt 1):50-60. doi: 10.1099/vir.0.034900-0. Epub 2011 Sep 21.
9
The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.抗黄热病毒NS1抗体的Fc部分是小鼠抵抗黄热脑炎的保护决定因素。
Virology. 1993 Jan;192(1):132-41. doi: 10.1006/viro.1993.1015.
10
Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library.通过筛选噬菌体展示随机肽文库鉴定西尼罗河病毒 NS1 中的两个线性 B 细胞表位。
BMC Microbiol. 2011 Jul 6;11:160. doi: 10.1186/1471-2180-11-160.

引用本文的文献

1
A Scoping Review of Preclinical Research on Monoclonal Antibody Development for Prophylaxis and Treatment of West Nile Virus Infections.用于预防和治疗西尼罗河病毒感染的单克隆抗体开发的临床前研究范围综述
Viruses. 2025 Jun 12;17(6):845. doi: 10.3390/v17060845.
2
A low pre-existing anti-NS1 humoral immunity to DENV is associated with microcephaly development after gestational ZIKV exposure.对登革热病毒(DENV)预先存在的低水平抗NS1体液免疫与孕期寨卡病毒(ZIKV)暴露后小头畸形的发生有关。
PLoS Negl Trop Dis. 2025 Jan 6;19(1):e0012193. doi: 10.1371/journal.pntd.0012193. eCollection 2025 Jan.
3
The N and C-terminal deleted variant of the dengue virus NS1 protein is a potential candidate for dengue vaccine development.登革病毒 NS1 蛋白的 N 端和 C 端缺失变体是登革热疫苗开发的潜在候选物。
Sci Rep. 2024 Aug 14;14(1):18883. doi: 10.1038/s41598-024-65593-1.
4
A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression .一种能够增强乙肝表面抗原免疫清除能力的糖基工程化治疗性抗乙肝病毒抗体可改善对乙肝病毒的抑制。
Front Pharmacol. 2023 Dec 27;14:1213726. doi: 10.3389/fphar.2023.1213726. eCollection 2023.
5
Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.用重组流感病毒和 MVA 诱导对 TBEV NS1 蛋白的体液和细胞免疫可提供针对小鼠致死性 TBEV 感染的部分保护。
Front Immunol. 2023 Jul 7;14:1177324. doi: 10.3389/fimmu.2023.1177324. eCollection 2023.
6
Novel approaches for the rapid development of rationally designed arbovirus vaccines.合理设计虫媒病毒疫苗快速研发的新方法。
One Health. 2023 May 13;16:100565. doi: 10.1016/j.onehlt.2023.100565. eCollection 2023 Jun.
7
Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions.登革热和寨卡病毒感染交叉反应的结构与免疫学基础:对流行地区血清学监测的影响
Front Microbiol. 2023 Mar 17;14:1107496. doi: 10.3389/fmicb.2023.1107496. eCollection 2023.
8
Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.动物模型中黄热病病毒候选mRNA疫苗的免疫原性和保护活性。
NPJ Vaccines. 2023 Mar 4;8(1):31. doi: 10.1038/s41541-023-00629-7.
9
Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies.日本脑炎的分子发病机制及可能的治疗策略。
Arch Virol. 2022 Sep;167(9):1739-1762. doi: 10.1007/s00705-022-05481-z. Epub 2022 Jun 2.
10
Cross-reactive antibodies targeting surface-exposed non-structural protein 1 (NS1) of dengue virus-infected cells recognize epitopes on the spaghetti loop of the β-ladder domain.靶向登革病毒感染细胞表面暴露的非结构蛋白1(NS1)的交叉反应性抗体识别β-阶梯结构域意大利面条环上的表位。
PLoS One. 2022 May 26;17(5):e0266136. doi: 10.1371/journal.pone.0266136. eCollection 2022.

本文引用的文献

1
Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis.黄病毒非结构蛋白NS1的分泌:从诊断到发病机制
Novartis Found Symp. 2006;277:233-47; discussion 247-53. doi: 10.1002/0470058005.ch17.
2
Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.一种重组亚单位西尼罗河疫苗候选物在保护仓鼠免受西尼罗河脑炎侵害方面的有效性和持久性。
Vaccine. 2007 Apr 12;25(15):2913-8. doi: 10.1016/j.vaccine.2006.08.008. Epub 2006 Aug 22.
3
DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.基于非结构蛋白1(ns1)基因的登革病毒DNA疫苗:不同信号序列对蛋白表达的影响及其与小鼠体内引发的免疫反应的相关性
Virology. 2007 Feb 20;358(2):413-23. doi: 10.1016/j.virol.2006.08.052. Epub 2006 Oct 3.
4
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.重组西尼罗河亚单位疫苗的制备及其免疫原性
Vaccine. 2007 Jan 5;25(3):414-23. doi: 10.1016/j.vaccine.2006.08.018. Epub 2006 Aug 30.
5
Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.西尼罗河病毒感染的发病机制:毒力、固有免疫和适应性免疫以及病毒逃避之间的平衡。
J Virol. 2006 Oct;80(19):9349-60. doi: 10.1128/JVI.01122-06.
6
Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.严重登革病毒感染中的血管渗漏:非结构病毒蛋白NS1和补体的潜在作用
J Infect Dis. 2006 Apr 15;193(8):1078-88. doi: 10.1086/500949. Epub 2006 Mar 9.
7
Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.针对西尼罗河病毒非结构蛋白NS1的抗体通过Fcγ受体依赖性和非依赖性机制预防致死性感染。
J Virol. 2006 Feb;80(3):1340-51. doi: 10.1128/JVI.80.3.1340-1351.2006.
8
Fcgamma receptors: old friends and new family members.Fcγ受体:老朋友与新家族成员
Immunity. 2006 Jan;24(1):19-28. doi: 10.1016/j.immuni.2005.11.010.
9
DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.DNA引发E和NS1构建体——同源蛋白增强免疫策略以改善小鼠对登革热的免疫反应。
Viral Immunol. 2005;18(4):709-21. doi: 10.1089/vim.2005.18.709.
10
CD8+ T cells require perforin to clear West Nile virus from infected neurons.CD8 + T细胞清除感染神经元中的西尼罗河病毒需要穿孔素。
J Virol. 2006 Jan;80(1):119-29. doi: 10.1128/JVI.80.1.119-129.2006.

细胞表面相关NS1的抗体识别触发Fc-γ受体介导的吞噬作用并清除西尼罗河病毒感染的细胞。

Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells.

作者信息

Chung Kyung Min, Thompson Bruce S, Fremont Daved H, Diamond Michael S

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

出版信息

J Virol. 2007 Sep;81(17):9551-5. doi: 10.1128/JVI.00879-07. Epub 2007 Jun 20.

DOI:10.1128/JVI.00879-07
PMID:17582005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1951387/
Abstract

Previous studies have suggested that monoclonal antibodies (MAbs) to flavivirus nonstructural protein-1 (NS-1) protect against infection in mice through an Fc-gamma receptor-dependent pathway. To identify a specific mechanism, we evaluated the protective activity of anti-NS1 MAbs to WNV using mice and cells with deficiencies of specific Fc-gamma receptors. Our results suggest that only MAbs that recognize cell surface-associated NS1 trigger Fc-gamma receptor I- and/or IV-mediated phagocytosis and clearance of WNV-infected cells. These findings may be relevant for generating novel therapeutic MAbs or vaccines against flaviviruses that target the NS1 protein.

摘要

先前的研究表明,针对黄病毒非结构蛋白1(NS-1)的单克隆抗体(MAbs)通过Fc-γ受体依赖性途径保护小鼠免受感染。为了确定具体机制,我们使用缺乏特定Fc-γ受体的小鼠和细胞评估了抗NS1单克隆抗体对西尼罗河病毒(WNV)的保护活性。我们的结果表明,只有识别细胞表面相关NS1的单克隆抗体才能触发Fc-γ受体I和/或IV介导的吞噬作用以及清除WNV感染的细胞。这些发现可能与开发针对靶向NS1蛋白的黄病毒的新型治疗性单克隆抗体或疫苗相关。